Press Releases - Lipella Pharmaceuticals, Inc.

Skip to content

HOME
ABOUT
TRIALS
- Hemorrhagic Cystitis Clinical Trial
- Radiation Cystitis Patient Registry
MANAGEMENT
PUBLICATIONS
- Press Releases
INVESTORS
Sliding Bar Toggle
Radition Cystitis Registry

Press ReleasesLipella Pharmaceuticals, Inc2023-02-07T19:09:45+00:00

Investors: Press Releases

Press Releases

Investors

Corporate Overview
SEC Filings
Press Releases
Stock Quote
Events & Presentations
Corporate Governance
FAQ’s
Investor Relations Contact

Lipella Pharmaceuticals Inc. Code of Ethics

CHARTERS:

Audit Committee Charter
Compensation Committee Charter
Nominating and Corporate Governance Charter

Lipella Pharmaceuticals Inc.
7800 Susquehanna St, Suite 505
Pittsburgh, PA 15208
USA

2023 © Copyright - Lipella Pharmaceuticals, Inc.

Close Sliding Bar Area

Recent Posts

Lipella Pharma Sees Positive Results for LP-10 Phase 2a Trial
Lipella Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock
Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry
Lipella Pharmaceuticals Announces Successful Completion of Pre-IND Type B FDA Meeting Regarding Oral Lichen Planus Drug Candidate
Bladder Health Foundation Launches Patient Registry for Survivors of Pelvic Radiation Therapy

Lipella Pharmaceuticals, Inc.

Phone: 412-894-1853

Email: Get In Touch Via Email

Reach Out

Investors

Corporate Overview
SEC Filings
Press Releases
Stock Quote
Events & Presentations
Corporate Governance
FAQ’s
Investor Relations Contact